Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC [Phase 2]
Phase 2 trial evaluating autogene cevumeran plus atezolizumab with mFOLFIRINOX versus mFOLFIRINOX in patients with resected pancreatic ducta…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing the safety and tolerability of JPI-547 in combination with Modified FOLFIRINOX or Gemcitabine-nab-pacli…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The KN510713 Study in Combination With mFOLFIRINOX [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating KN510713 in combination with mFOLFIRINOX for locally advanced or metastatic pancreatic ductal adenocar…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
A Phase 3 clinical trial evaluating chemotherapy with or without INCB161734 in untreated metastatic pancreatic ductal adenocarcinoma with KR…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating GDC-0449 (vismodegib) and erlotinib hydrochloride, with or without gemcitabine hydrochloride, in metastatic pancrea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial evaluating cemiplimab plus gemcitabine for metastatic pancreatic ductal adenocarcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors [Phase 1, Phase 2]
GEN1042 is being evaluated in a Phase 1/2 safety study with indications across malignant solid tumors, including non-small cell lung cancer,…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors [Phase 1]
Phase 1 study update for RMC-6291 monotherapy in KRASG12C-mutant solid tumors, outlining dose-escalation and dose-expansion cohorts in subje…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer [Phase 3]
A Phase 3 trial is evaluating higher-dose radiation therapy for locally advanced unresectable pancreatic ductal adenocarcinoma, and recruitm…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue [Phase 2, Phase 3]
ClinicalTrials.gov update describes a Phase 2/Phase 3 study of Ponsegromab in adults with metastatic pancreatic ductal adenocarcinoma and ca…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma [NA]
This clinical trial entry describes a study evaluating a polygenic risk score to predict the risk of pancreatic ductal adenocarcinoma, with …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for PF-08046052/SGN-EGFRd2 in advanced solid tumors, including colorectal cancer, non-small cell lung cancer, …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating perioperative fostamatinib in combination with gemcitabine and nab-paclitaxel for resectable pancreatic ductal aden…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers
This clinical trial update outlines an early detection study for pancreatic ductal adenocarcinoma using a biomarker panel, which is currentl…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
A completed study comparing TDTP-RECIST with RECIST 1.1 and other volumetric methods to evaluate therapeutic response in irregular malignant…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric [NA]
Update on the POP-UP trial, a single-arm, two-cohort study evaluating an 8-week trimodal prehabilitation program for patients with pancreati…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 3]
A Phase 3 clinical trial evaluating Daraxonrasib alone and in combination with gemcitabine and nab-paclitaxel as first-line therapy for meta…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
A Phase 3 clinical trial evaluating Daraxonrasib (RMC-6236) in patients with resected pancreatic ductal adenocarcinoma is currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Advanced Therapies for Liver Metastases
Clinical trial update from IRCCS San Raffaele notes ongoing recruitment for advanced therapies targeting liver metastases, with indications …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II) [EARLY_Phase 1]
Feasibility study of Suizenji in unresectable pancreatic ductal adenocarcinoma (SUNRISE-II) is an early-phase trial currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations [Phase 1]
Phase 1 study to evaluate ALTA3263 in adults with KRAS-mutant advanced solid tumors, including pancreatic ductal adenocarcinoma, non-small c…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1]
A Phase 1 clinical trial of PTM-101 for pancreatic ductal adenocarcinoma and related locally advanced or borderline resectable disease is cu…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours [Phase 1]
Clinical trial update describes a Phase 1 dose-escalation study of [225Ac]-FPI-2068 in adults with advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With Pancreatic Cancer [Phase 1]
Phase 1 study evaluating Boehringer Ingelheim's KISIMA-02 vaccine-based immunotherapy in combination with ezabenlimab for pancreatic ductal …
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
This clinical trial update outlines the Pancreas Interception Center (PIC) focused on early detection, prevention, and novel therapeutics fo…